Author:
Karachaliou Georgia Sofia,Kaye Deborah R.,George Daniel J.,Zhang Tian
Publisher
Springer International Publishing
Reference55 articles.
1. Miller DC, Ruterbusch J, Colt JS, et al. Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. J Urol [Internet]. 2010;184(6):2254–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20952033
2. Ghali F, Patel SH, Derweesh IH. Current status of immunotherapy for localized and locally advanced renal cell carcinoma. J Oncol [Internet]. 2019;2019:7309205. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31057615
3. Chow W-H, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol [Internet]. 2010;7(5):245–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20448658
4. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer [Internet]. 2008;113(1):78–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18491376
5. Martinez Chanza N, Tripathi A, Harshman LC. Adjuvant therapy options in renal cell carcinoma: where do we stand? Curr Treat Options Oncol [Internet]. 2019;20(5):44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31054006